nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.0036	0.0036	CcSEcCtD
Betahistine—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00358	0.00358	CcSEcCtD
Betahistine—Dyspepsia—Etidronic acid—osteoporosis	0.00353	0.00353	CcSEcCtD
Betahistine—Discomfort—Alendronate—osteoporosis	0.00353	0.00353	CcSEcCtD
Betahistine—Immune system disorder—Risedronate—osteoporosis	0.00349	0.00349	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00349	0.00349	CcSEcCtD
Betahistine—Anaphylactic shock—Estropipate—osteoporosis	0.00347	0.00347	CcSEcCtD
Betahistine—Convulsion—Calcitriol—osteoporosis	0.00346	0.00346	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00345	0.00345	CcSEcCtD
Betahistine—Discomfort—Ibandronate—osteoporosis	0.00343	0.00343	CcSEcCtD
Betahistine—Abdominal pain upper—Estradiol—osteoporosis	0.00341	0.00341	CcSEcCtD
Betahistine—Nervous system disorder—Estropipate—osteoporosis	0.00341	0.00341	CcSEcCtD
Betahistine—Skin disorder—Estropipate—osteoporosis	0.00337	0.00337	CcSEcCtD
Betahistine—Discomfort—Calcitriol—osteoporosis	0.00336	0.00336	CcSEcCtD
Betahistine—Anaphylactic shock—Ibandronate—osteoporosis	0.00333	0.00333	CcSEcCtD
Betahistine—Immune system disorder—Pamidronate—osteoporosis	0.00332	0.00332	CcSEcCtD
Betahistine—Flatulence—Risedronate—osteoporosis	0.00331	0.00331	CcSEcCtD
Betahistine—Feeling abnormal—Etidronic acid—osteoporosis	0.00331	0.00331	CcSEcCtD
Betahistine—Nervous system disorder—Raloxifene—osteoporosis	0.0033	0.0033	CcSEcCtD
Betahistine—Skin disorder—Raloxifene—osteoporosis	0.00327	0.00327	CcSEcCtD
Betahistine—Nervous system disorder—Ibandronate—osteoporosis	0.00327	0.00327	CcSEcCtD
Betahistine—Anaphylactic shock—Calcitriol—osteoporosis	0.00326	0.00326	CcSEcCtD
Betahistine—Abdominal distension—Estradiol—osteoporosis	0.00325	0.00325	CcSEcCtD
Betahistine—Skin disorder—Ibandronate—osteoporosis	0.00323	0.00323	CcSEcCtD
Betahistine—Asthma—Estradiol—osteoporosis	0.00323	0.00323	CcSEcCtD
Betahistine—Nausea—Ergocalciferol—osteoporosis	0.00321	0.00321	CcSEcCtD
Betahistine—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.0032	0.0032	CcSEcCtD
Betahistine—Urticaria—Etidronic acid—osteoporosis	0.00319	0.00319	CcSEcCtD
Betahistine—Bronchospasm—Estradiol—osteoporosis	0.00318	0.00318	CcSEcCtD
Betahistine—Skin disorder—Calcitriol—osteoporosis	0.00317	0.00317	CcSEcCtD
Betahistine—Angioedema—Ethinyl Estradiol—osteoporosis	0.00315	0.00315	CcSEcCtD
Betahistine—Malaise—Ethinyl Estradiol—osteoporosis	0.00311	0.00311	CcSEcCtD
Betahistine—Somnolence—Estropipate—osteoporosis	0.00309	0.00309	CcSEcCtD
Betahistine—Angioedema—Risedronate—osteoporosis	0.00307	0.00307	CcSEcCtD
Betahistine—Dyspepsia—Estropipate—osteoporosis	0.00306	0.00306	CcSEcCtD
Betahistine—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.00305	0.00305	CcSEcCtD
Betahistine—Immune system disorder—Zoledronate—osteoporosis	0.00303	0.00303	CcSEcCtD
Betahistine—Dyspepsia—Alendronate—osteoporosis	0.00301	0.00301	CcSEcCtD
Betahistine—Gastrointestinal disorder—Estropipate—osteoporosis	0.003	0.003	CcSEcCtD
Betahistine—Fatigue—Estropipate—osteoporosis	0.00299	0.00299	CcSEcCtD
Betahistine—Ill-defined disorder—Pamidronate—osteoporosis	0.00297	0.00297	CcSEcCtD
Betahistine—Dyspepsia—Raloxifene—osteoporosis	0.00296	0.00296	CcSEcCtD
Betahistine—Hypersensitivity—Etidronic acid—osteoporosis	0.00296	0.00296	CcSEcCtD
Betahistine—Dyspepsia—Ibandronate—osteoporosis	0.00293	0.00293	CcSEcCtD
Betahistine—Angioedema—Pamidronate—osteoporosis	0.00292	0.00292	CcSEcCtD
Betahistine—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00292	0.00292	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00292	0.00292	CcSEcCtD
Betahistine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.0029	0.0029	CcSEcCtD
Betahistine—Discomfort—Ethinyl Estradiol—osteoporosis	0.0029	0.0029	CcSEcCtD
Betahistine—Somnolence—Calcitriol—osteoporosis	0.0029	0.0029	CcSEcCtD
Betahistine—Malaise—Pamidronate—osteoporosis	0.00288	0.00288	CcSEcCtD
Betahistine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00288	0.00288	CcSEcCtD
Betahistine—Fatigue—Ibandronate—osteoporosis	0.00287	0.00287	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00284	0.00284	CcSEcCtD
Betahistine—Pruritus—Etidronic acid—osteoporosis	0.00284	0.00284	CcSEcCtD
Betahistine—Feeling abnormal—Alendronate—osteoporosis	0.00282	0.00282	CcSEcCtD
Betahistine—Flatulence—Conjugated Estrogens—osteoporosis	0.00277	0.00277	CcSEcCtD
Betahistine—Convulsion—Pamidronate—osteoporosis	0.00277	0.00277	CcSEcCtD
Betahistine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00276	0.00276	CcSEcCtD
Betahistine—Urticaria—Estropipate—osteoporosis	0.00276	0.00276	CcSEcCtD
Betahistine—Diarrhoea—Etidronic acid—osteoporosis	0.00275	0.00275	CcSEcCtD
Betahistine—Feeling abnormal—Ibandronate—osteoporosis	0.00274	0.00274	CcSEcCtD
Betahistine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00273	0.00273	CcSEcCtD
Betahistine—Urticaria—Alendronate—osteoporosis	0.00272	0.00272	CcSEcCtD
Betahistine—Ill-defined disorder—Zoledronate—osteoporosis	0.00271	0.00271	CcSEcCtD
Betahistine—Nervous system disorder—Risedronate—osteoporosis	0.00269	0.00269	CcSEcCtD
Betahistine—Discomfort—Pamidronate—osteoporosis	0.00269	0.00269	CcSEcCtD
Betahistine—Angioedema—Zoledronate—osteoporosis	0.00267	0.00267	CcSEcCtD
Betahistine—Skin disorder—Risedronate—osteoporosis	0.00267	0.00267	CcSEcCtD
Betahistine—Urticaria—Ibandronate—osteoporosis	0.00265	0.00265	CcSEcCtD
Betahistine—Malaise—Zoledronate—osteoporosis	0.00263	0.00263	CcSEcCtD
Betahistine—Confusional state—Pamidronate—osteoporosis	0.00263	0.00263	CcSEcCtD
Betahistine—Anaphylactic shock—Pamidronate—osteoporosis	0.00261	0.00261	CcSEcCtD
Betahistine—Urticaria—Calcitriol—osteoporosis	0.00259	0.00259	CcSEcCtD
Betahistine—Angioedema—Conjugated Estrogens—osteoporosis	0.00257	0.00257	CcSEcCtD
Betahistine—Hypersensitivity—Estropipate—osteoporosis	0.00256	0.00256	CcSEcCtD
Betahistine—Nervous system disorder—Pamidronate—osteoporosis	0.00256	0.00256	CcSEcCtD
Betahistine—Vomiting—Etidronic acid—osteoporosis	0.00255	0.00255	CcSEcCtD
Betahistine—Tachycardia—Pamidronate—osteoporosis	0.00255	0.00255	CcSEcCtD
Betahistine—Rash—Etidronic acid—osteoporosis	0.00253	0.00253	CcSEcCtD
Betahistine—Convulsion—Zoledronate—osteoporosis	0.00253	0.00253	CcSEcCtD
Betahistine—Dermatitis—Etidronic acid—osteoporosis	0.00253	0.00253	CcSEcCtD
Betahistine—Hypersensitivity—Alendronate—osteoporosis	0.00252	0.00252	CcSEcCtD
Betahistine—Headache—Etidronic acid—osteoporosis	0.00251	0.00251	CcSEcCtD
Betahistine—Asthenia—Estropipate—osteoporosis	0.00249	0.00249	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00247	0.00247	CcSEcCtD
Betahistine—Pruritus—Estropipate—osteoporosis	0.00246	0.00246	CcSEcCtD
Betahistine—Discomfort—Zoledronate—osteoporosis	0.00246	0.00246	CcSEcCtD
Betahistine—Asthenia—Alendronate—osteoporosis	0.00245	0.00245	CcSEcCtD
Betahistine—Hypersensitivity—Ibandronate—osteoporosis	0.00245	0.00245	CcSEcCtD
Betahistine—Dyspnoea—Risedronate—osteoporosis	0.00245	0.00245	CcSEcCtD
Betahistine—Erythema multiforme—Estradiol—osteoporosis	0.00244	0.00244	CcSEcCtD
Betahistine—Convulsion—Conjugated Estrogens—osteoporosis	0.00244	0.00244	CcSEcCtD
Betahistine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00243	0.00243	CcSEcCtD
Betahistine—Fatigue—Ethinyl Estradiol—osteoporosis	0.00243	0.00243	CcSEcCtD
Betahistine—Pruritus—Alendronate—osteoporosis	0.00242	0.00242	CcSEcCtD
Betahistine—Dyspepsia—Risedronate—osteoporosis	0.00242	0.00242	CcSEcCtD
Betahistine—Confusional state—Zoledronate—osteoporosis	0.0024	0.0024	CcSEcCtD
Betahistine—Hypersensitivity—Calcitriol—osteoporosis	0.0024	0.0024	CcSEcCtD
Betahistine—Asthenia—Ibandronate—osteoporosis	0.00239	0.00239	CcSEcCtD
Betahistine—Nausea—Etidronic acid—osteoporosis	0.00238	0.00238	CcSEcCtD
Betahistine—Anaphylactic shock—Zoledronate—osteoporosis	0.00238	0.00238	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00238	0.00238	CcSEcCtD
Betahistine—Diarrhoea—Estropipate—osteoporosis	0.00238	0.00238	CcSEcCtD
Betahistine—Gastrointestinal disorder—Risedronate—osteoporosis	0.00237	0.00237	CcSEcCtD
Betahistine—Fatigue—Risedronate—osteoporosis	0.00237	0.00237	CcSEcCtD
Betahistine—Pruritus—Ibandronate—osteoporosis	0.00236	0.00236	CcSEcCtD
Betahistine—Diarrhoea—Alendronate—osteoporosis	0.00234	0.00234	CcSEcCtD
Betahistine—Asthenia—Calcitriol—osteoporosis	0.00234	0.00234	CcSEcCtD
Betahistine—Nervous system disorder—Zoledronate—osteoporosis	0.00234	0.00234	CcSEcCtD
Betahistine—Immune system disorder—Estradiol—osteoporosis	0.00233	0.00233	CcSEcCtD
Betahistine—Dyspnoea—Pamidronate—osteoporosis	0.00233	0.00233	CcSEcCtD
Betahistine—Tachycardia—Zoledronate—osteoporosis	0.00233	0.00233	CcSEcCtD
Betahistine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00232	0.00232	CcSEcCtD
Betahistine—Somnolence—Pamidronate—osteoporosis	0.00232	0.00232	CcSEcCtD
Betahistine—Skin disorder—Zoledronate—osteoporosis	0.00231	0.00231	CcSEcCtD
Betahistine—Pruritus—Calcitriol—osteoporosis	0.00231	0.00231	CcSEcCtD
Betahistine—Diarrhoea—Raloxifene—osteoporosis	0.0023	0.0023	CcSEcCtD
Betahistine—Dyspepsia—Pamidronate—osteoporosis	0.0023	0.0023	CcSEcCtD
Betahistine—Dizziness—Estropipate—osteoporosis	0.0023	0.0023	CcSEcCtD
Betahistine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00229	0.00229	CcSEcCtD
Betahistine—Diarrhoea—Ibandronate—osteoporosis	0.00228	0.00228	CcSEcCtD
Betahistine—Dizziness—Alendronate—osteoporosis	0.00226	0.00226	CcSEcCtD
Betahistine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00225	0.00225	CcSEcCtD
Betahistine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00225	0.00225	CcSEcCtD
Betahistine—Fatigue—Pamidronate—osteoporosis	0.00225	0.00225	CcSEcCtD
Betahistine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00224	0.00224	CcSEcCtD
Betahistine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00224	0.00224	CcSEcCtD
Betahistine—Diarrhoea—Calcitriol—osteoporosis	0.00223	0.00223	CcSEcCtD
Betahistine—Skin disorder—Conjugated Estrogens—osteoporosis	0.00223	0.00223	CcSEcCtD
Betahistine—Dizziness—Raloxifene—osteoporosis	0.00222	0.00222	CcSEcCtD
Betahistine—Flatulence—Estradiol—osteoporosis	0.00222	0.00222	CcSEcCtD
Betahistine—Vomiting—Estropipate—osteoporosis	0.00221	0.00221	CcSEcCtD
Betahistine—Dizziness—Ibandronate—osteoporosis	0.0022	0.0022	CcSEcCtD
Betahistine—Rash—Estropipate—osteoporosis	0.00219	0.00219	CcSEcCtD
Betahistine—Dermatitis—Estropipate—osteoporosis	0.00219	0.00219	CcSEcCtD
Betahistine—Urticaria—Risedronate—osteoporosis	0.00218	0.00218	CcSEcCtD
Betahistine—Headache—Estropipate—osteoporosis	0.00218	0.00218	CcSEcCtD
Betahistine—Vomiting—Alendronate—osteoporosis	0.00217	0.00217	CcSEcCtD
Betahistine—Rash—Alendronate—osteoporosis	0.00216	0.00216	CcSEcCtD
Betahistine—Dermatitis—Alendronate—osteoporosis	0.00215	0.00215	CcSEcCtD
Betahistine—Feeling abnormal—Pamidronate—osteoporosis	0.00215	0.00215	CcSEcCtD
Betahistine—Headache—Alendronate—osteoporosis	0.00214	0.00214	CcSEcCtD
Betahistine—Vomiting—Raloxifene—osteoporosis	0.00214	0.00214	CcSEcCtD
Betahistine—Dyspnoea—Zoledronate—osteoporosis	0.00212	0.00212	CcSEcCtD
Betahistine—Rash—Raloxifene—osteoporosis	0.00212	0.00212	CcSEcCtD
Betahistine—Dermatitis—Raloxifene—osteoporosis	0.00212	0.00212	CcSEcCtD
Betahistine—Somnolence—Zoledronate—osteoporosis	0.00212	0.00212	CcSEcCtD
Betahistine—Vomiting—Ibandronate—osteoporosis	0.00212	0.00212	CcSEcCtD
Betahistine—Headache—Raloxifene—osteoporosis	0.00211	0.00211	CcSEcCtD
Betahistine—Rash—Ibandronate—osteoporosis	0.0021	0.0021	CcSEcCtD
Betahistine—Dermatitis—Ibandronate—osteoporosis	0.0021	0.0021	CcSEcCtD
Betahistine—Dyspepsia—Zoledronate—osteoporosis	0.0021	0.0021	CcSEcCtD
Betahistine—Ill-defined disorder—Estradiol—osteoporosis	0.00209	0.00209	CcSEcCtD
Betahistine—Headache—Ibandronate—osteoporosis	0.00209	0.00209	CcSEcCtD
Betahistine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00207	0.00207	CcSEcCtD
Betahistine—Vomiting—Calcitriol—osteoporosis	0.00207	0.00207	CcSEcCtD
Betahistine—Nausea—Estropipate—osteoporosis	0.00206	0.00206	CcSEcCtD
Betahistine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00206	0.00206	CcSEcCtD
Betahistine—Angioedema—Estradiol—osteoporosis	0.00206	0.00206	CcSEcCtD
Betahistine—Rash—Calcitriol—osteoporosis	0.00206	0.00206	CcSEcCtD
Betahistine—Fatigue—Zoledronate—osteoporosis	0.00205	0.00205	CcSEcCtD
Betahistine—Dermatitis—Calcitriol—osteoporosis	0.00205	0.00205	CcSEcCtD
Betahistine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00205	0.00205	CcSEcCtD
Betahistine—Headache—Calcitriol—osteoporosis	0.00204	0.00204	CcSEcCtD
Betahistine—Somnolence—Conjugated Estrogens—osteoporosis	0.00204	0.00204	CcSEcCtD
Betahistine—Nausea—Alendronate—osteoporosis	0.00203	0.00203	CcSEcCtD
Betahistine—Malaise—Estradiol—osteoporosis	0.00203	0.00203	CcSEcCtD
Betahistine—Hypersensitivity—Risedronate—osteoporosis	0.00202	0.00202	CcSEcCtD
Betahistine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00202	0.00202	CcSEcCtD
Betahistine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00202	0.00202	CcSEcCtD
Betahistine—Nausea—Raloxifene—osteoporosis	0.002	0.002	CcSEcCtD
Betahistine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00199	0.00199	CcSEcCtD
Betahistine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00198	0.00198	CcSEcCtD
Betahistine—Fatigue—Conjugated Estrogens—osteoporosis	0.00198	0.00198	CcSEcCtD
Betahistine—Nausea—Ibandronate—osteoporosis	0.00198	0.00198	CcSEcCtD
Betahistine—Asthenia—Risedronate—osteoporosis	0.00197	0.00197	CcSEcCtD
Betahistine—Feeling abnormal—Zoledronate—osteoporosis	0.00196	0.00196	CcSEcCtD
Betahistine—Pruritus—Risedronate—osteoporosis	0.00194	0.00194	CcSEcCtD
Betahistine—Nausea—Calcitriol—osteoporosis	0.00194	0.00194	CcSEcCtD
Betahistine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00193	0.00193	CcSEcCtD
Betahistine—Hypersensitivity—Pamidronate—osteoporosis	0.00192	0.00192	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.0019	0.0019	CcSEcCtD
Betahistine—Urticaria—Zoledronate—osteoporosis	0.00189	0.00189	CcSEcCtD
Betahistine—Discomfort—Estradiol—osteoporosis	0.00189	0.00189	CcSEcCtD
Betahistine—Diarrhoea—Risedronate—osteoporosis	0.00188	0.00188	CcSEcCtD
Betahistine—Asthenia—Pamidronate—osteoporosis	0.00187	0.00187	CcSEcCtD
Betahistine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00186	0.00186	CcSEcCtD
Betahistine—Confusional state—Estradiol—osteoporosis	0.00185	0.00185	CcSEcCtD
Betahistine—Pruritus—Pamidronate—osteoporosis	0.00185	0.00185	CcSEcCtD
Betahistine—Anaphylactic shock—Estradiol—osteoporosis	0.00184	0.00184	CcSEcCtD
Betahistine—Urticaria—Conjugated Estrogens—osteoporosis	0.00182	0.00182	CcSEcCtD
Betahistine—Dizziness—Risedronate—osteoporosis	0.00181	0.00181	CcSEcCtD
Betahistine—Nervous system disorder—Estradiol—osteoporosis	0.0018	0.0018	CcSEcCtD
Betahistine—Tachycardia—Estradiol—osteoporosis	0.00179	0.00179	CcSEcCtD
Betahistine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00179	0.00179	CcSEcCtD
Betahistine—Diarrhoea—Pamidronate—osteoporosis	0.00179	0.00179	CcSEcCtD
Betahistine—Skin disorder—Estradiol—osteoporosis	0.00178	0.00178	CcSEcCtD
Betahistine—Rash—Ethinyl Estradiol—osteoporosis	0.00177	0.00177	CcSEcCtD
Betahistine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00177	0.00177	CcSEcCtD
Betahistine—Headache—Ethinyl Estradiol—osteoporosis	0.00176	0.00176	CcSEcCtD
Betahistine—Hypersensitivity—Zoledronate—osteoporosis	0.00176	0.00176	CcSEcCtD
Betahistine—Vomiting—Risedronate—osteoporosis	0.00175	0.00175	CcSEcCtD
Betahistine—Rash—Risedronate—osteoporosis	0.00173	0.00173	CcSEcCtD
Betahistine—Dermatitis—Risedronate—osteoporosis	0.00173	0.00173	CcSEcCtD
Betahistine—Dizziness—Pamidronate—osteoporosis	0.00173	0.00173	CcSEcCtD
Betahistine—Headache—Risedronate—osteoporosis	0.00172	0.00172	CcSEcCtD
Betahistine—Asthenia—Zoledronate—osteoporosis	0.00171	0.00171	CcSEcCtD
Betahistine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00169	0.00169	CcSEcCtD
Betahistine—Pruritus—Zoledronate—osteoporosis	0.00169	0.00169	CcSEcCtD
Betahistine—Nausea—Ethinyl Estradiol—osteoporosis	0.00167	0.00167	CcSEcCtD
Betahistine—Vomiting—Pamidronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Betahistine—Asthenia—Conjugated Estrogens—osteoporosis	0.00165	0.00165	CcSEcCtD
Betahistine—Rash—Pamidronate—osteoporosis	0.00165	0.00165	CcSEcCtD
Betahistine—Dermatitis—Pamidronate—osteoporosis	0.00164	0.00164	CcSEcCtD
Betahistine—Dyspnoea—Estradiol—osteoporosis	0.00164	0.00164	CcSEcCtD
Betahistine—Headache—Pamidronate—osteoporosis	0.00163	0.00163	CcSEcCtD
Betahistine—Somnolence—Estradiol—osteoporosis	0.00163	0.00163	CcSEcCtD
Betahistine—Diarrhoea—Zoledronate—osteoporosis	0.00163	0.00163	CcSEcCtD
Betahistine—Nausea—Risedronate—osteoporosis	0.00163	0.00163	CcSEcCtD
Betahistine—Pruritus—Conjugated Estrogens—osteoporosis	0.00162	0.00162	CcSEcCtD
Betahistine—Dyspepsia—Estradiol—osteoporosis	0.00162	0.00162	CcSEcCtD
Betahistine—Gastrointestinal disorder—Estradiol—osteoporosis	0.00159	0.00159	CcSEcCtD
Betahistine—Fatigue—Estradiol—osteoporosis	0.00158	0.00158	CcSEcCtD
Betahistine—Dizziness—Zoledronate—osteoporosis	0.00158	0.00158	CcSEcCtD
Betahistine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00157	0.00157	CcSEcCtD
Betahistine—Nausea—Pamidronate—osteoporosis	0.00155	0.00155	CcSEcCtD
Betahistine—Dizziness—Conjugated Estrogens—osteoporosis	0.00152	0.00152	CcSEcCtD
Betahistine—Vomiting—Zoledronate—osteoporosis	0.00152	0.00152	CcSEcCtD
Betahistine—Feeling abnormal—Estradiol—osteoporosis	0.00151	0.00151	CcSEcCtD
Betahistine—Rash—Zoledronate—osteoporosis	0.0015	0.0015	CcSEcCtD
Betahistine—Dermatitis—Zoledronate—osteoporosis	0.0015	0.0015	CcSEcCtD
Betahistine—Headache—Zoledronate—osteoporosis	0.00149	0.00149	CcSEcCtD
Betahistine—Vomiting—Conjugated Estrogens—osteoporosis	0.00146	0.00146	CcSEcCtD
Betahistine—Urticaria—Estradiol—osteoporosis	0.00146	0.00146	CcSEcCtD
Betahistine—Rash—Conjugated Estrogens—osteoporosis	0.00145	0.00145	CcSEcCtD
Betahistine—Dermatitis—Conjugated Estrogens—osteoporosis	0.00145	0.00145	CcSEcCtD
Betahistine—Headache—Conjugated Estrogens—osteoporosis	0.00144	0.00144	CcSEcCtD
Betahistine—Nausea—Zoledronate—osteoporosis	0.00142	0.00142	CcSEcCtD
Betahistine—Nausea—Conjugated Estrogens—osteoporosis	0.00136	0.00136	CcSEcCtD
Betahistine—Hypersensitivity—Estradiol—osteoporosis	0.00135	0.00135	CcSEcCtD
Betahistine—Asthenia—Estradiol—osteoporosis	0.00132	0.00132	CcSEcCtD
Betahistine—Pruritus—Estradiol—osteoporosis	0.0013	0.0013	CcSEcCtD
Betahistine—Diarrhoea—Estradiol—osteoporosis	0.00126	0.00126	CcSEcCtD
Betahistine—Dizziness—Estradiol—osteoporosis	0.00121	0.00121	CcSEcCtD
Betahistine—Vomiting—Estradiol—osteoporosis	0.00117	0.00117	CcSEcCtD
Betahistine—Rash—Estradiol—osteoporosis	0.00116	0.00116	CcSEcCtD
Betahistine—Dermatitis—Estradiol—osteoporosis	0.00116	0.00116	CcSEcCtD
Betahistine—Headache—Estradiol—osteoporosis	0.00115	0.00115	CcSEcCtD
Betahistine—Nausea—Estradiol—osteoporosis	0.00109	0.00109	CcSEcCtD
